Related Experiment Video
Updated: Dec 30, 2025

Noninvasive Determination of Vortex Formation Time Using Transesophageal Echocardiography During Cardiac Surgery
Published on: November 28, 2018
No increased extracellular volume fraction or conduction time after childhood septal myectomy
Julia Schleihauf1, Julie Cleuziou2, Christian Meierhofer1
1Department of Congenital Heart Disease and Pediatric Cardiology, German Heart Center Munich, Technical University of Munich, Munich, Germany.
Insights
Surgical septal myectomy in childhood for hypertrophic cardiomyopathy does not increase myocardial fibrosis or conduction problems. This procedure is safe for managing left ventricular outflow tract obstruction long-term.
Area of Science:
- Cardiology
- Pediatric Cardiology
- Cardiovascular Imaging
Background:
- Hypertrophic cardiomyopathy (HCM) is a genetic heart muscle disease.
- Severe HCM in children can cause left ventricular outflow tract obstruction (LVOTO).
- Surgical septal myectomy is a treatment option for drug-refractory LVOTO in pediatric HCM.
Purpose of the Study:
- To evaluate the long-term effects of early childhood septal myectomy on myocardial extracellular volume fraction.
- To assess the risk of atrioventricular conduction system disease after pediatric septal myectomy.
- To investigate the impact of septal myectomy on myocardial fibrosis in pediatric HCM.
Main Methods:
- Retrospective review of 30 pediatric HCM patients.
- Cardiovascular magnetic resonance (CMR) with T1 mapping and late gadolinium enhancement.
- Comparison between 12 myectomy patients and 18 non-operated patients.
Main Results:
- Septal myocardial fibrosis (late gadolinium enhancement) was present in 53% of patients, with no group difference.
- Extracellular volume fraction, a marker of diffuse fibrosis, was similar in myectomy and non-operated groups.
- No significant difference in PQ-intervals or higher-degree atrioventricular conduction disease between groups.
Conclusions:
- Pediatric septal myectomy does not increase septal extracellular volume fraction.
- The procedure does not lead to delayed atrioventricular conduction times on long-term follow-up.
- Septal myectomy is a safe intervention for severe obstructive HCM in early childhood.
Objectives:
The aim of this study was to assess the effect of surgical septal myectomy performed during early childhood for severe, drug-refractory hypertrophic cardiomyopathy with left ventricular outflow tract obstruction on the extent of septal myocardial extracellular volume fraction and the potential risk of developing atrioventricular cardiac conduction system disease.
Methods:
In this retrospective study, data from 30 patients with a confirmed diagnosis of childhood-onset hypertrophic cardiomyopathy were reviewed including cardiovascular magnetic resonance (CMR) with myocardial T1 mapping and late gadolinium enhancement, histopathology of myocardial specimens, transthoracic echocardiography, electrocardiography, 24-h Holter and cardiopulmonary exercise testing. Eighteen patients without were compared to 12 patients with prior septal myectomy performed during childhood (non-operated versus myectomy patients).
Results:
Late gadolinium enhancement on CMR as a correlate for focal myocardial fibrosis was found in 53% of patients, predominantly located in the septal region, with no difference between groups. As compared to non-operated patients, those after myectomy showed a similar amount of total and septal extracellular volume fraction, as calculated from pre- and post-contrast CMR T1 mapping, which is a correlate for diffuse interstitial myocardial fibrosis. PQ-intervals or the occurrence of higher degree conduction system disease were equal between the 2 groups.
Conclusions:
Data from CMR and electrocardiography suggest that surgical septal myectomy performed during early childhood for severe obstructive hypertrophic cardiomyopathy does not cause an increased septal extracellular volume fraction or delayed atrioventricular conduction time on long-term follow-up.
More Related Videos
Related Concept Videos
Mitral Stenosis I: Introduction
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral Stenosis III: Medical Management
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Heart Failure II: Pathophysiology

